10,646 followers
New Research: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus: Erenumab is the first human monoclonal antibody to be approved as a selective… https://t.co/9vc